
In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …

The Department of Health is putting £120 million of new funding into health research over the next five years in …

England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …
The Department of Health has signalled its desire to make a splash in the digital pond with the release of …

The NHS Commissioning Board’s blueprint for care has promised extra funds for health providers and greater transparency for patients. Board …

The NHS’s possible move to seven-day working has received a mixed welcome, with the BMA dubbing the proposals ‘too crude’. …
NICE has published its first guidance on good practice for those involved in working out what medicines should be made …
The government looks to be heading towards a showdown with clinician groups over proposed changes to doctors’ contracts. It has …
The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …

In a landmark development for the controversial Health and Social Care Act, the first clinical commissioning groups (CCGs) have taken …

The volume of GP-prescribed drugs grew by an annual average of 8.4% in the years 1995-2010, according to new government …

Pharma will only form lasting relationships with the NHS in future by demonstrating its value, according to Kevin Blakemore, NHS …